Stock Scorecard



Stock Summary for Qiagen NV (QGEN) - $41.01 as of 4/10/2026 5:13:02 PM EST

Total Score

10 out of 30

Safety Score

37 out of 100

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for QGEN

Positive Quarterly and Annual earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the Annual earnings growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for QGEN

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for QGEN

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for QGEN

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for QGEN (37 out of 100)

Stock Price Rating (Max of 10) 8
Historical Stock Price Rating (Max of 10) 8
Stock Price Trend (Max of 10) 2
Book Value (Max of 10) 6
Book Value to Price (Max of 10) 0
Analyst Buy Ratings (Max of 5) 4
Analyst Strong Buy Ratings (Max of 5) 4
Dividend Yield Percentage (Max of 10) 1
Operating Margin (Max of 10) 5
Trading Volume (Max of 10) 9
Price to Earnings (Max of 10) 0
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) -10

Latest News for for QGEN

Barclays Maintains Qiagen NV(QGEN.US) With Hold Rating, Maintains Target Price $44 4/15/2026 11:39:00 AM
Qiagen expands into bloodstream infection syndromic testing with new rapid QIAstat-Dx panel 4/15/2026 7:10:00 AM
Qiagen N.V. stock (NL0012169213): Why does its sample-to-insight business model matter more for U.S. 4/15/2026 4:10:00 AM
Qiagen launches bloodstream infection testing panel By Investing.com 4/14/2026 9:10:00 PM
QIAGEN launches bloodstream infection testing panel 4/14/2026 8:07:00 PM
QIAGEN Expands Into Bloodstream Infection Syndromic Testing With New Rapid QIAstat-Dx Panel 4/14/2026 8:04:00 PM
Precision Trading with Qiagen N.v. (QGEN) Risk Zones 4/14/2026 9:10:00 AM
Qiagen N.V. stock (NL0012169213): Is sample-to-insight leadership strong enough to unlock new upside 4/14/2026 9:09:00 AM
Qiagen N.V. stock (NL0012169213): Why does its molecular diagnostics edge matter more now for U.S. investors? 4/14/2026 6:40:00 AM
Qiagen N.V. stock (NL0012169213): Does its genomics leadership deliver the biotech stability U.S. investors seek? 4/12/2026 4:10:00 PM

Financial Details for QGEN

Company Overview

Ticker QGEN
Company Name Qiagen NV
Country N/A
Description QIAGEN NV provides sample-to-knowledge solutions that transform biological materials into molecular knowledge globally. The company is headquartered in Venlo, the Netherlands.
Sector Name HEALTHCARE
Industry Name DIAGNOSTICS & RESEARCH
Most Recent Quarter 12/31/2025
Next Earnings Date 5/6/2026

Stock Price History

Last Day Price 41.01
Price 4 Years Ago 49.95
Last Day Price Updated 4/10/2026 5:13:02 PM EST
Last Day Volume 1,113,980
Average Daily Volume 1,899,840
52-Week High 57.82
52-Week Low 37.77
Last Price to 52 Week Low 8.58%

Valuation Measures

Trailing PE N/A
Industry PE 29.86
Sector PE 56.25
5-Year Average PE 24.27
Free Cash Flow Ratio 10.08
Industry Free Cash Flow Ratio 20.11
Sector Free Cash Flow Ratio 19.70
Current Ratio Most Recent Quarter 3.90
Total Cash Per Share 4.07
Book Value Per Share Most Recent Quarter 18.33
Price to Book Ratio 2.22
Industry Price to Book Ratio 7.43
Sector Price to Book Ratio 8.32
Price to Sales Ratio Twelve Trailing Months 4.04
Industry Price to Sales Ratio Twelve Trailing Months 3.54
Sector Price to Sales Ratio Twelve Trailing Months 23.35
Analyst Buy Ratings 4
Analyst Strong Buy Ratings 4

Share Statistics

Total Shares Outstanding 206,075,000
Market Capitalization 8,451,135,750
Institutional Ownership N/A

Dividends

Ex-Dividend Date 1/8/2026
Previous Dividend Amount 2.4105
Current Dividend Amount 0.2632
Total Years Dividend Increasing 1
Trailing Annual Dividend Rate 0.26
Trailing Annual Dividend Yield 0.64%
Forward Annual Dividend Rate 0.26
Forward Annual Dividend Yield 0.64%
5-Year Dividend Payments Count 4
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio 12.90%

Income Statement

Quarterly Earnings Growth YOY 21.90%
Annual Earnings Growth 408.28%
Reported EPS 12 Trailing Months 2.04
Reported EPS Past Year 0.00
Reported EPS Prior Year 2.34
Net Income Twelve Trailing Months 424,880,000
Net Income Past Year 424,880,000
Net Income Prior Year 83,591,000
Quarterly Revenue Growth YOY 3.70%
5-Year Revenue Growth 2.25%
Operating Margin Twelve Trailing Months 27.40%

Balance Sheet

Total Cash Most Recent Quarter 839,005,000
Total Cash Past Year 839,005,000
Total Cash Prior Year 663,555,000
Net Cash Position Most Recent Quarter -815,423,000
Net Cash Position Past Year -815,423,000
Long Term Debt Past Year 1,654,428,000
Long Term Debt Prior Year 1,338,067,000
Total Debt Most Recent Quarter 1,654,428,000
Equity to Debt Ratio Past Year 0.70
Equity to Debt Ratio Most Recent Quarter 0.70
Total Stockholder Equity Past Year 3,778,154,000
Total Stockholder Equity Prior Year 3,567,339,000
Total Stockholder Equity Most Recent Quarter 3,778,154,000

Free Cash Flow

Free Cash Flow Twelve Trailing Months 452,631,000
Free Cash Flow Per Share Twelve Trailing Months 2.20
Free Cash Flow Past Year 453,277,000
Free Cash Flow Prior Year 506,377,000

Options

Put/Call Ratio 0.25
Has Options Options Chain
Liquidity Rating

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD -1.09
MACD Signal -1.53
20-Day Bollinger Lower Band 37.07
20-Day Bollinger Middle Band 46.12
20-Day Bollinger Upper Band 55.17
Beta 0.79
RSI 42.56
50-Day SMA 46.54
150-Day SMA 0.00
200-Day SMA 0.00

System

Modified 4/14/2026 6:15:50 AM EST